Ginkgo biloba is an herbal extract derived from the leaves of the Ginkgo tree, containing flavonoids and terpene lactones as primary active compounds. It works primarily through antioxidant mechanisms and vasodilation to improve blood flow, particularly cerebral circulation. Commonly used for cognitive enhancement, memory support, and management of age-related cognitive decline, though efficacy remains controversial in clinical research.

Overview

Ginkgo biloba is derived from the leaves of the maidenhair tree (Ginkgo biloba L.), a living fossil that has remained essentially unchanged for over 200 million years. It is the most widely sold herbal supplement for cognitive support globally, with standardized extracts (EGb 761 being the most researched) containing approximately 24% flavone glycosides (quercetin, kaempferol, and isorhamnetin derivatives) and 6% terpene lactones (ginkgolides A, B, C, J and bilobalide). These compounds work synergistically to improve microcirculation, protect against oxidative damage, and modulate neurotransmitter systems.

The primary mechanism of ginkgo's cognitive effects involves enhancement of cerebral blood flow through vasodilation (primarily mediated by nitric oxide release), reduction in blood viscosity, and platelet-activating factor (PAF) antagonism by ginkgolide B. These vascular effects improve oxygen and glucose delivery to brain tissue. Additionally, the flavonoid components provide robust neuroprotection by scavenging free radicals, chelating pro-oxidant transition metals, and stabilizing cell membranes. Clinical evidence supports its use in age-related cognitive decline and dementia, where meta-analyses have shown improvements in cognitive function, daily activities, and neuropsychiatric symptoms with doses of 120–240 mg of standardized extract daily.

While the large GEM (Ginkgo Evaluation of Memory) trial did not find preventive effects against dementia in healthy older adults, numerous smaller trials and meta-analyses support benefits in individuals with existing mild cognitive impairment or dementia. Ginkgo also has clinical evidence for peripheral arterial disease (improving walking distance in intermittent claudication), tinnitus, vertigo, and macular degeneration. It is generally well-tolerated, though its antiplatelet activity warrants caution when combined with blood thinners or before surgery. Ginkgo is frequently combined with ginseng in cognitive support formulations.

Mechanism of Action

Dual Active Constituent Classes

Ginkgo biloba extract (standardized as EGb 761) contains two principal bioactive groups: terpene trilactones (ginkgolides A, B, C, J and bilobalide, 6% of extract) and flavonoid glycosides (quercetin, kaempferol, isorhamnetin derivatives, 24% of extract). These constituents act through complementary but distinct mechanisms to produce the extract's neurovascular and neuroprotective effects (PMID: 11535361).

PAF Antagonism & Vascular Effects

Ginkgolides (especially ginkgolide B) are potent and specific antagonists of platelet-activating factor (PAF) receptors. By competitively blocking PAF binding, ginkgolides inhibit platelet aggregation, reduce vascular permeability, and suppress PAF-mediated bronchoconstriction and inflammatory cell chemotaxis. This anti-PAF activity reduces blood viscosity and improves microcirculation, particularly in the cerebral and peripheral vasculature (PMID: 10735185).

Neuroprotective Mechanisms

Bilobalide protects neurons against excitotoxicity by modulating GABA-A receptor function and preserving mitochondrial membrane potential during ischemic stress. The flavonoid components scavenge superoxide, hydroxyl, and peroxyl radicals and chelate pro-oxidant transition metals (Fe2+, Cu2+). EGb 761 inhibits MAO-A and MAO-B activity, reduces amyloid-beta aggregation, and upregulates BDNF and NGF expression via CREB phosphorylation, supporting synaptic plasticity (PMID: 20633368).

Nitric Oxide & Endothelial Function

Ginkgo flavonoids stimulate endothelial nitric oxide synthase (eNOS) activity through PI3K/Akt-mediated phosphorylation at Ser1177, increasing nitric oxide (NO) bioavailability. This promotes vasodilation, inhibits smooth muscle proliferation, and reduces leukocyte-endothelial adhesion. The antioxidant capacity of the extract also protects NO from inactivation by superoxide, preventing peroxynitrite formation (PMID: 12020920).

Reconstitution Calculator

Research

Safety Profile

Common Side Effects

• Headache is the most commonly reported side effect, occurring in approximately 5–10% of users
• Gastrointestinal symptoms including nausea, upset stomach, diarrhea, and abdominal discomfort
• Dizziness and lightheadedness, particularly when standing quickly, related to blood pressure effects
• Allergic skin reactions including rash, itching, and contact dermatitis (especially with fresh leaf preparations)
• Increased bleeding tendency, including nosebleeds and easy bruising, due to potent antiplatelet activity
• Heart palpitations reported occasionally

Serious Adverse Effects

• Spontaneous bleeding events including intracranial hemorrhage (brain bleeds) have been reported, particularly in patients concurrently using anticoagulants or antiplatelet drugs; this is the most serious documented risk
• Seizures have been reported, attributed to ginkgotoxin (4-O-methylpyridoxine), a compound present in ginkgo seeds and in smaller amounts in leaves; standardized extracts (EGb 761) minimize but may not entirely eliminate this risk
• Severe allergic reactions and anaphylaxis, though rare
• Priapism has been reported in isolated case reports
• Liver toxicity with raw or non-standardized preparations; ginkgolic acids present in crude extracts are known hepatotoxins and should be below 5 ppm in quality products

Contraindications

• Contraindicated in individuals with bleeding disorders (hemophilia, von Willebrand disease, thrombocytopenia)
• Individuals on anticoagulant or antiplatelet therapy should not use ginkgo without physician approval
• Must be discontinued at least two weeks before any surgical or dental procedure due to significant bleeding risk
• Individuals with epilepsy or lowered seizure threshold should avoid use due to ginkgotoxin content
• Pregnant and breastfeeding women should avoid use due to antiplatelet effects and insufficient reproductive safety data
• Not recommended for children under 12

Drug Interactions

• Clinically significant and potentially dangerous interaction with warfarin, heparin, and direct oral anticoagulants (DOACs); documented cases of serious bleeding events
• Potentiates antiplatelet drugs (aspirin, clopidogrel, ticagrelor, prasugrel) and NSAIDs (ibuprofen, naproxen)
• May reduce the effectiveness of anticonvulsant medications by lowering seizure threshold
• Interacts with SSRIs and other serotonergic drugs; cases of serotonin syndrome have been reported when combined with fluoxetine or sertraline
• Induces CYP2C19 and may reduce efficacy of proton pump inhibitors (omeprazole), certain antidepressants, and antifungals
• May interact with diabetes medications by affecting insulin secretion and glucose metabolism
• Trazodone combined with ginkgo has resulted in coma in at least one case report

Population-Specific Considerations

• Older adults are the primary user population and are also at highest risk for bleeding complications and drug interactions due to polypharmacy
• Only use standardized extracts (EGb 761 or equivalent) with verified low ginkgolic acid content
• The EGb 761 extract has been studied in large clinical trials (GuidAge, GEM) with a generally acceptable safety profile under controlled conditions

Pharmacokinetic Profile